Back to Journals » Clinical Pharmacology: Advances and Applications » Volume 4

Smoking cessation

Authors Kaur K, Juneja, Kaushal

Received 29 January 2012

Accepted for publication 2 February 2012

Published 15 March 2012 Volume 2012:4 Pages 21—22

DOI https://doi.org/10.2147/CPAA.S30323


Kirandeep Kaur, Shivani Juneja, Sandeep Kaushal
Department of Pharmacology, Dayanand Medical College and Hospital, Ludhiana, Punjab, India

With reference to the article published under the title "Pharmacologic agents for smoking cessation: A clinical review", we would like to add some information related to smoking cessation therapy among pregnant females. In that article, in the nicotine replacement therapy section, pregnancy has been considered as a contraindication to the use of transdermal patches, gum, lozenges, nasal sprays, and oral inhalers containing nicotine.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]